rd Annual Report - Orion Infusion Ltd · 5 Strategic Business Units WHO ... of the Annual Report together with the Audited Financial Statements including Statement of Financial ...

F i n a n c i a l Y e a r 2 0 1 5 - 2 0 1 6Annual Report33rd

Annual Report 2016 0

Contents

011 Orion Group2 Vision, Mission & Values3 Landmarks of Orion5 Strategic Business Units

WHO WE ARE

1719 Message from the Chairman21 Key Facts22 Highlights of Our Performance23 Financial Performance24 Graphical View25 32nd Annual General Meeting

ACCOMPLISHMENTS& RESULTS

2729 Corporate Chronology31 Vision, Mission, Goals & Values32 Organogram33 OIL Structure 34 Business Strategy35 Business Model37 The Code of Business Ethics39 Compliance Statement41 Stakeholder Analysis43 Value Chain Analysis44 Quality Policy45 Distribution Network46 Global Footprint47 Product Index48 New Products Launched49 Risks Management Systems51 Statement of Corporate Governance53 33rd Annual General Meeting Notice

OUR BUSINESS & STRATEGY

0709 At a Glance10 Profile of the Company11 Corporate Information12 Corporate Bodies13 Profile of Directors

ABOUT ORION INFUSION

Annual Report 20160A

Contents

5557 Human Resource Development61 Environmental Facet64 Corporate Social Responsibility67 Value Added Statement68 Share Performance

SUSTAINABILITY REPORTING

6971 Directors' Report

77 Shareholding Information

79 Compliance of Notification

No.SEC/CMRRCD/2006158/134/Admin/44

81 Audit Committee Report

84 Report of the CEO & CFO to the Board

85 Compliance Report on BAS & BFRS

86 Certification on Compliance of Corporate Governance

87 Statement of Compliance with Corporate Governance

94 Independent Auditor's Report

95 Statement of Financial Position as at June 30, 2016

96 Statement of Comprehensive Income for the year ended June 30, 2016

97 Statement of Changes in Equity for the year ended June 30, 2016

98 Statement for the Cash Flows for the year ended June 30, 2016

99 Notes to the Financial Statements for the year ended June 30, 2016

REPORTS & FINANCIAL RESULTS

Annual Report 2016 0B

All Shareholders

Registrar of Joint Stock Companies & Firms

Bangladesh Securities and Exchange Commission

Dhaka Stock Exchange Limited and

Chittagong Stock Exchange Limited.

Dear Sir/Madam (s):

ANNUAL REPORT FOR THE YEAR ENDED JUNE 30, 2016

We are pleased to inform you that the Board of Directors of Orion Infusion Ltd. has taken the decision, in its Board

Meeting held on November 08, 2016, to hold 33rd Annual General Meeting of the Company on December 20, 2016.

In accordance with the requirement of Bangladesh Securities and Exchange Commission, we are enclosing a copy

of the Annual Report together with the Audited Financial Statements including Statement of Financial Position as

at June 30, 2016, Statement of Comprehensive Income, Statement of Changes in Equity and Statement of Cash

Flows for the year then ended June 30, 2016 along with notes as well as the Directors' Report of the Company

thereon for your record/necessary measures.

Yours sincerely

Sd/-

Md. Ferdous Jaman

Company Secretary

Dated: November 08, 2016

Letter of Transmittal

Annual Report 20160C

Annual Report 2016 0D

Who We Are

Annual Report 201601

ORION GROUP is a leading and continuously thriving corporation and a legendary brand name in the business arena of Bangladesh and beyond. Orion has a long history of determination, commitment towards excellence, integrity, and a firm promise to deliver value to its consumers and clients since early '80s.

Orion Group is endowed with a highly diversified portfolio of Pharma & Healthcare, Power Generation & Energy, shipping, Infrastructure Development, Real Estate & Construction, Cosmetics & Toiletries, High-tech Agro Products, Food & Restaurant Chain, Textiles & Garments and Home Appliance sectors. Apart from significant contribution in the aforesaid sectors, Orion in recent times has exclusively focused in Power Generation & Energy, Engineering & Construction and Infrastructure Development sectors. Going further to Orion's continuous success, Orion is now on the verge of exploring and developing the untapped Hospitality & Tourism sector of Bangladesh through its commitment in implementing the largest Tourism Resort and Entertainment Village in South Asia, located along the mesmerizing coastline of world's longest Sea Beach Cox's Bazar.

Orion Group has been an integral part in the steady economic growth and significantly increasing socio-economic development of Bangladesh in the past two decades through its contribution in the Trade & Commerce sector of Bangladesh, one of the Next-11 countries possessing high potential for economic growth as analyzed by Goldman Sachs. Orion has long since been consistently successful in all major investment undertakings so far and significantly contributed to the country's business environment, growth and stability through its adoption of appropriate business to business, business to government and business to consumers strategies and made an astonishing effort with a desire for excellence and creating value, be it introducing a new brand for consumers or forging a promising public private partnership with the Government of Bangladesh. Being a growth and development-oriented business entity, Orion never stepped back to forge partnership with the Government, Transnational Corporations and to involve foreign technological expertise in its multifaceted ventures as and when required.

ORION GROUP


VISION, MISSION & VALUES

To be regarded as a world-class corporate house through products, services and values.

VISIONQuality in everything we do

Transparent and fair in all our dealings

Take initiatives to exceed standards

Trust and respect to each other

Work as a team

Share social responsibility

VALUES

Continuous development of people competency

Recognizing individual contribution

Introducing new and innovative products and technologies

Assuring quality products from advanced manufacturing facilities

Exceeding customer satisfaction and granting trust through quality services

MISSION


The LONGEST Elevated Expressway and the FIRST PPP project in the country on BOOT basis; the 11.8 km long "Mayor Mohammad Hanif Flyover"

FASTEST HFO based 2 power projects in the country which were constructed in just record 9 months time from contract signing

The TALLEST Building in the country, "City Centre"; a 37-storied commercial complex cum multistoried car parking at Motijheel, Dhaka

LANDMARKS OF ORION

Mayor Mohammad Hanif Flyover

City Center

HFO Based Power Plant


Implementing LARGEST single unit power plant 4x680 MW Ultra-Supercritical Coal based IPPs in the country

The BIGGEST Mushroom processing & freezing plant in the country, a 100% export oriented 'Baby Button Mushroom' producer

Constructing the BIGGEST state-of-the-art Pharmaceutical Complex (Pharma Park) in Bangladesh

Awarded to implement first ever PPP Project in Tourism Sector at Cox's Bazar, will be the LARGEST entertainment COMPLEX in South Asia

Coal Based IPPs

Pharma Park

Tourism Resort & Entertainment

Mushroom Project


Dutch-Bangla Power & Associates Ltd.

Orion Power Meghnaghat Ltd.

Orion Agro Products Ltd.

Jafflong Tea Company Ltd.Orion Infrastructure Ltd.

Noakhali Gold Foods Ltd.

Orion Pharma Ltd.

Orion Oil & Shipping Ltd.

Interior Accom Consortium Ltd.

Orion Power Dhaka Ltd.

Orion Power Chittagong Ltd.

Orion Power Unit-2 Dhak Ltd.

Orion Power Unit-3 Dhak Ltd.

Pharma &Healthcare

InfrastructureDevelopment

Construction& AlliedPower Energy Agro Products

Orion Power Khulna Ltd.

STRATEGIC BUSINESS UNITS


City CentreKohinoor Chemical Company Ltd. Orion Knit Textiles Ltd.Orion Footwear Ltd.

TM

seafood in a pan

Orion Restaurants Ltd.

Orion Properties Ltd.

Orion Home Appliance Ltd.

Cosmetics &Toiletries

Footwear &Footcare

HomeAppliance Real Estate Textiles &

GarmentsFood &

Beverage


About Orion Infusion



No. of Therapeutic Class: 09Nature of Business: Manufacturing and marketing of Large Volume Parenterals (LVP)

No. of Presentation: 38Production Area: 7,171 Square Meters

No. of Generics: 24No. of Brands: 24

Product Categories:

Fat Emulsion

Antiulcerant

Nutrient &

Electrolyte

Replenishers

Antimicrobials

Fluid

Amino Acid Supplement Plasma Substitute

Fluid

AT A GLANCE


Orion Infusion Limited (OIL) was incorporated in 1983 as a state-of-the-art Large Volume Parenterals (LVP) manufacturing company. At its inception, the company was named as "Mala Chemical & Pharmaceutical Industries Ltd," which was changed to Orion Infusion Limited in 1994. In the same year, the company also became a public limited company and was listed in DSE. Subsequently in 1996, the company was enlisted with CSE as well.

OIL is one of the leading pharmaceutical companies in Bangladesh with cutting edge technologies for manufacturing and marketing of IV Fluid, lifesaving intravenous and intravascular saline like Rehydration Solution, Electrolyte Solution, Antiulcerant Solution viz. Ranitidine IV, Amino Acid Solution, Antimicrobial products viz. Ciprofloxacin IV, Metronidazole IV, Ceftrixone IV & Plazma Substitute viz. Hydroxyethyl Strach Solution, ensuring commitment over quality.

With its modest start, more than three decades ago with the mission to improve the health of people of Bangladesh, OIL has today burgeoned out into the leading infusion companies in Bangladesh. It has already established itself to the doctors' community, other health care professionals, chemists and patients as a provider of quality medicines and health care services.

An al R t 2016

PROFILE OF THE COMPANY


Registered Name of the Company

Legal Form

Business Line

Listing Status

Registered and Corporate Office

Location of Production Plant

Authorized Capital

Paid-up Capital

Number of Shareholders

Number of Employees

Company E-mail

Company Website

Audit Committee

Chief Financial Officer

Company Secretary

Chief Internal Auditor

Auditor

Principal Bankers

Insurers

Orion Infusion Limited

Public Limited Company incorporated in Bangladesh on May 5, 1983

Manufacturing and marketing of Large Volume Parenterals (LVP)

Listed with Dhaka Stock Exchange and Chittagong Stock Exchange

ORION HOUSE153- 154, Tejgaon Industrial Area Dhaka- 1208, Bangladesh

Maikuli, P.S.- Rupganj, District- Narayanganj, Bangladesh

BDT 1,000,000,000

BDT 203,597,600

5,032

794

[email protected]

www.orioninfusion.com

Mr. Golam MohiuddinMr. Salman Obaidul KarimMrs. Arzuda Karim

Mr. Samaresh Banik

Mr. Md. Ferdous Jaman

Mr. Md. Ibrahim Khalil

M/S. Khan Wahab Shafique Rahman & Co.Chartered AccountantsRupali Bima Bhaban, 7, Rajuk Avenue(5th Floor), Dhaka-1000, Bangladesh

Agrani Bank LimitedSonali Bank LimitedNational Bank LimitedShahjalal Islami Bank LimitedBank Asia Limited

Islami Commercial Insurance Co. LimitedIslami Insurance Bangladesh Limited

CORPORATE INFORMATION


No. of IndependentDirector

No. of IndependentDirector

COMMITTEE MEMBERSBOARD MEMBERS

Chairman:

Mr. Mohammad Obaidul Karim

Managing Director:

Mr. Salman Obaidul Karim

Directors:

Mrs. Arzuda Karim

Mrs. Zareen Karim

Independent Director:

Mr. Golam Mohiuddin

Management Team

Chairman:


Members:

Mr. Samaresh Banik

Mr. Talim Khashru

Mr. Binoy Krishna Barai

Mr. Harunor Rashid

Mr. Sazed Karim

Audit Committee

Chairman:

Mr. Golam Mohiuddin

Members:


Mr. Arzuda Karim

N/A

1 ou

t of

3 mem

bers

1 o

ut

of

5 m

emb

ers

CORPORATE BODIES


MR. MOHAMMAD OBAIDUL KARIM

Age: 61

Position: Chairman

Reappointed: In 2015

Qualification: Graduate, University of Dhaka

Directorships: Chairman of all concerns of Orion Group which include Orion Pharma Limited, Orion Infusion Limited, Kohinoor Chemical Co. (BD) Limited, Orion Infrastructure Limited, Orion Hospitals Limited, City Centre, Orion Power Meghnaghat Limited, Dutch Bangla Power & Associates Limited, Digital Power & Associates Limited, Orion Power Dhaka Limited, Orion Power Khulna Limited, Orion Power Unit-2 Dhaka Limited, Orion Gas Limited, Orion Agro Products Limited, Orion Footwear Limited, Orion Home Appliance Limited, Orion Restaurant Limited, Noakhali Gold Foods Limited, Orion Oil & Shipping Limited, Orion Holdings Limited, Orion Capital Limited etc.

Mohammad Obaidul Karim is a distinguished self-achieved Industrialist & Businessman. He is the Founder Chairman of ORION GROUP and established the company into one of the largest conglomerates in Bangladesh with his futuristic attitude, determined will and a burning passion. He is an innovative, self-motivated and enterprising Bangladeshi business icon who has instrumented his success in the field of diversified business portfolios. Orion Group comprised of more than 30 individual companies was formed under his dynamic leadership and management power which have received various industrial recognitions.

Mr. Karim is one of the first entrepreneurs in the country to recognize the importance of Public Private Partnership (PPP). Under his leadership, Orion Group constructed and owns the 11.8km long Mayor Mohammad Hanif Flyover, the longest flyover and the first ever successful PPP project of the nation. With Mr. Karim's headship, Orion Group also built City Centre, the tallest commercial complex cum car parking in Motijheel, the financial hub of Bangladesh. Mr. Karim's success went further up when the Group became successfully involved in Private Sector Power generation of the Country, when it signed the biggest contract with Bangladesh Power Development Board (BPDB) of 4 supercritical Coal based power plants of 3000MW (with 300MW present distribution) under IPP, under the Ministry of Power of the Government of Bangladesh.

Besides being the Chairman of Orion Group, Mr. Karim is also the Founder Chairman of Tejgaon Industrial Owners Association. He is also the President of Dhaka Mohamedan Sporting Club Ltd., a century old legendary and most successful sporting club of the country.

PROFILE OF DIRECTORS


MR. SALMAN OBAIDUL KARIM

Age: 35

Position: Managing Director and Chief Executive Officer

Appointed: In 2014

Qualification: Graduated in Business & Computing Management, Brunel University, UK

Directorships: Managing Director of major concerns of Orion Group which include Orion Pharma Limited, Orion Infusion Limited, Orion Infrastructure Limited, City Centre, Orion Hospitals Limited, Orion Knit Textile Limited, Orion Power Meghnaghat Limited, Dutch Bangla Power & Associates Limited, Digital Power & Associates Limited, Orion Power Dhaka Limited, Orion Power Khulna Limited, Orion Power Unit-2 Dhaka Limited, Orion Gas Limited, Orion Agro Products Limited, Orion Footwear Limited, Orion Home Appliance Limited, Orion Restaurant Limited, Noakhali Gold Foods Limited, Orion Capital Limited, Orion Properties Limited, Orion Oil & Shipping Limited, Orion Holdings Limited and Jafflong Tea Company Limited.

Salman Obaidul Karim is a distinguished and ingenious businessman in Bangladesh. Born only in 1981 and being guided by his father Mr. Mohammad Obaidul Karim, Salman Karim has become one of the most young and successful entrepreneurs of the country. Under his leadership, Orion's sustainability efforts were given outstanding shapes through his unique business concepts and visionary leadership skills. Besides his graduation, he experienced a couple of professional trainings in the Brunel UK and Harvard USA. After completing his study in the UK he came back to Bangladesh and joined the family business Orion Group. He has been involved with Orion Group and holds directorship of most of the sister concerns of Orion Group since 2005.


MRS. ARZUDA KARIM

Age: 60

Position: Founder Director


Qualification: Masters in Social Science, University of Dhaka

Directorships: Chairman of Jafflong Tea Company Limited and Director of major concerns of Orion Group amongst which includes Orion Pharma Limited, Orion Infusion Limited, Kohinoor Chemical Co.(BD) Limited, Orion Infrastructure Limited, Orion Hospitals Limited, Orion Power Meghnaghat Limited, Dutch Bangla Power & Associates Limited, Digital Power & Associates Limited, Orion Power Dhaka Limited, Orion Power Khulna Limited, Orion Power Unit-2 Dhaka Limited, Orion Gas Limited, Orion Agro Products Limited, Orion Footwear Limited, Noakhali Gold Foods Limited, Orion Oil & Shipping Limited, Orion Holdings Limited and Orion Capital Limited.

Mrs. Arzuda Karim is the wife of Mohammad Obaidul Karim. She has been one of the most successful women entrepreneurs in Bangladesh over the years. Mrs. Karim supervises production and commercial divisions of different segments of Orion Group. Her skill, knowledge and adaptability in pharmaceutical production and commercial areas are the main reasons of success in the Group.

MRS. ZAREEN KARIM

Age: 38

Position: Director


Qualification: MBA in Marketing, North South University

Directorships: Director of Orion Pharma Limited, Orion Infusion Limited and Orion Holdings Limited.

Mrs. Zareen Karim is the daughter of Mohammad Obaidul karim. She is one of the successful young entrepreneurs of the country and has been involved with different business activities since her early career. Besides being involved with Orion Group, Mrs. Zareen is also the Director of Star Associates Limited and Zeysha Fashionwear Limited with her husband.

Her hidden entrepreneurial potentials have gradually changed herself with the growing sensitivity to the role and economic status in the business society. As 'Women Entrepreneur' she accepts challenging role to meet her personal needs and become economically independent.

PROFILE OF DIRECTORS Continued


MR. GOLAM MOHIUDDINAge: 67Position: Independent DirectorReappointed: In 2015Qualification: B. Pharm (hons), University of Dhaka

Directorships: He is the Independent Director of Orion Infusion Limited as well as Orion Pharma Limited.

Mr. Mohiuddin joined the Company in 2012 as an Independent Director. He spent more than 21 years with Orion Infusion Limited as the Technical Director of Orion Infusion Limited (as an Advisor). He has experienced a number of Pharmaceutical Manufacturing Technology trainings from India, Japan, Holland, U.K. and Italy. He spent more than 10 years working as the Operative Director of Navana Pharmaceutical limited. His experience spans over more than four decades of eventful and illustrious career in pharmaceutical manufacturing sector and he was directly responsible for setting up two large Pharmaceutical plants including Intra Venous manufacturing.


Accomplishments & ResultsAnnual Report 2016 18


Distinguished Shareholders of Orion Infusion Family,

As-salamu Alaikum

I am happy to reminisce about what a year 2015 was! From achieving success towards attaining the Millennium Development Goals to becoming a Lower-Middle Income Country, Bangladesh has come a long way in terms of both economic and social development. A strong GDP growth, improved investment climate and increased local demand contributed towards better economic prospects for Bangladesh. I wish and pray for the continued success of the country, as this will ultimately help us to prosper in our individual businesses and lives.

I would now like to take the opportunity to welcome you all to our 33rd Annual General Meeting (AGM). It gives me further pleasure to announce that your Company has done immensely well in all the aspects of the business and has exceeded all our expectations and forecasts. I am happy to say that the performance of your company during the first six months of the reporting financial year; i.e. from July to December 2015, was remarkable but it performed even better during the last six months of the reporting year; i.e. from January to June 2016.

Dear friends, I will now take the opportunity of taking you all over the financial details. I am pleased to inform that your Company attained a Net Revenue of BDT 730.127 million as against BDT 662.837 million of the previous year, registering a praiseworthy positive growth of 10.15% over the previous year. During the present financial year, Gross Profit stood at BDT 288.453 million reflecting a positive growth of 10.45% and the Net Profit reached to BDT 106.985 million which is also higher than the previous year's Net Profit of BDT 28.25 million by a glorious 278.69%. It can be mentioned here that, this extraordinary growth in Net Profit was a result of increased sales in our core business operations as well as a huge Capital Gain on Marketable Securities.

Honorable Shareholders, it is a matter of joy for us all that the Earnings per Share (EPS) for the year 2015-16 is BDT 5.25 compared to previous year's EPS of BDT 1.39. The Return on Equity (ROE) enhanced to 40.50% from 15.07% and the Return on Asset (ROA) increased to 15.12% from 3.93%. Taking into account the extraordinary financial performance of the company this year, your Board has recommended 14% Cash Dividend to be appropriated from the profits to the shareholders for the financial year 2015-16.

Your Company always believes in continuously improving our operations and innovating new products to satisfy the customer base. We continue to work on improving our medicines quality and optimizing our

medicine range. Keeping this in mind, this year we have introduced Proliv Power and Salpac and are optimistic that it will prove to be a good source of revenue for your Company.

Every year your Company makes a significant contribution to the National Exchequer. During the financial year 2015-16, we contributed an amount of BDT 158.93 million in the form of Corporate Tax, Value Added Tax (VAT) and different other duties. This contribution is equivalent to 21.77% of the company's Net Revenue.

My dear fellow shareholders, we would like to assure you that we abide by all relevant guidelines and are committed to comply with all compliance requirements in a timely manner, in the matters involving the mandatory code of Corporate Governance for listed companies issued by Bangladesh Securities and Exchange Commission (BSEC). Disclosure in compliance with the codes has been set out in the Annual Report.

Along with its financial activities, your Company plays an active role in social and charity programs. For the future of our country, we always take an active part in different types of educational and social welfare projects. As we move ahead, we will try to be more involved in the social welfare of the country. You will be happy to know that your Company adopts environment-friendly technology and to keep the business ahead of the competition, we at Orion Infusion Limited continually adjust our strategies to reflect the environment in which we operate.

I would now like to take the opportunity to thank you all, my dear friends, for your never ending support and faith upon us. Your valued suggestions, advices and continuous supports are the driving forces behind the growth and development of this business. I would also like to sincerely appreciate all our valued stakeholders including business partners, customers, bankers, suppliers, government agencies, regulatory authorities and everyone with whom the company interacted with in conducting its business. All our employees have done an admirable job in contributing to our success, and on behalf of all the shareholders, I would like to applaud all our employees for doing such a commendable job. I wish and pray for the continued success of the company in the future.

Thank you,

Sd/-Mohammad Obaidul KarimChairman

MESSAGE FROM THE CHAIRMAN


†Pqvig¨vb-Gi cÖwZ‡e`b

Avm&mvjvgy AvjvBKzg

Avwg AZ¨š— Avb‡›ì m‡½ 2015-†K ¯§iY KiwQ! mnmªvã Dbœqbj¶¨gvÎv AR©‡b Kvw•LZ AMÖMwZ jvf Kivi cvkvcvwk wbgœ gaÄv‡qi †`‡k wb‡R‡ì DbœxZ Kivi gva¨‡g evsjv‡`k A_©‰bwZKGes mvgvwRK Dfq †¶‡ÎB Abe`¨ mvdj¨ AR©b K‡i‡Q| m‡š—vlRbK wRwWwci nvi, wewb‡qvM eë¯’vi DbœwZ Ges m‡e©vcwiAf¨š—ixb evRv‡ii m¤úªmvi‡Yi gva¨‡g †`kxq Pvwn`v e„w×evsjv‡`‡ki A_©‰bwZK Dbœq‡bi c‡_ weivU f~wgKv cvjb K‡i‡Q|Avgiv Avkv Kwi †`‡ki GB Dbœq‡bi µgaviv †hb AvMvgx w`b¸‡jv‡ZI Ae¨vnZ _v‡K hv Avgv‡ì cÖ‡Z¨‡Ki eëmvwqKj¶¨gvÎv AR©‡b P~ovš—fv‡e mvnvh¨ Ki‡e |

wcªq †kqvi‡nvìvie„›`, Avcbv‡ì mevB‡K Iwiqb BbwdDk‡bi33Zg evwl©K mvavib mfvq ¯^vMZg| Avwg AZ¨š— Avb‡›ì mv‡_Rvbvw”Q †h, Avgv‡ì †Kv¤úvbx Av‡jvP¨ A_©eQ‡ii Rb¨ wba©vwiZj¶¨gvÎv AwZµg Ki‡Z mdj n‡q‡Q| 2015-16 A_©eQ‡iicy‡iv mgq Ry‡oB †Kv¤úvbx Zvi Dbœq‡bi aviv eRvq †i‡L‡Q|we‡kl K‡i †kl cÖvwš—‡K Avgv‡ì Av‡qi cÖe„w× wQj j¶¨bxq|

m¤§vbxZ g‡nv`qMY, Avwg GLb Avcbv‡ì mvg‡b 2015-16 A_©eQ‡ii Avw_©K cÖwZ‡e`‡bi mvi ms‡¶c Zz‡j aiwQ| Avwg mš‘wói mv‡_ Avcbv‡ì AeMZ Ki‡Z PvB †h, G A_©eQ‡iAvgv‡ì bxU weµq 10.15% e„w× †c‡q 730.127 wgwjqb UvKv n‡q‡Q hv weMZ eQ‡i wQj 662.837 wgwjqb UvKv| †gvU jvf 10.45% e„w× †c‡q `vwo‡q‡Q 288.453 wgwjqb UvKv Ges bxU jvf AwR©Z n‡q‡Q 106.985 wgwjqb UvKv hv weMZ eQ‡iiZzjbvq 278.69% †ewk| Avgv‡ì eëmvwqK Kvh©µ‡giAvkvbyiƒc cÖe„w× Ges evRviRvZ‡hvM¨ wmwKDwiwUR weµ‡qi d‡jg~jabRwbZ jvf AR©‡bi d‡j bxU gybvdvq G ai‡bi j¶¨bxqcÖe„w× n‡q‡Q|

m¤§vbxZ †kqvi‡nvìvie„›`, Avgv‡ì mevi Rb¨ Avb‡›ì e¨vcviGB †h, Av‡jvP¨ eQ‡i †kqvi cÖwZ Avq n‡q‡Q 5.25 UvKv hv weMZ eQ‡i wQj 1.33 UvKv, wiUvb© Ab BK¨zBwU 15.07% †_‡Ke„w× †c‡q n‡q‡Q 40.50% Ges wiUvb© Ab A¨v‡mU 3.93% †_‡K e„w× †c‡q 2015-16 A_©eQ‡i n‡q‡Q 15.12%| †Kv¤úvbxi mvgwMÖK Avw_©K Ae¯’v we‡ePbv K‡i Avcbv‡ì †Kv¤úvbxi cwiPvjbv cl©` Av‡jvP¨ A_©eQ‡ii Rb¨ 14% bM` jf¨vsk †`qvi mycvwik K‡i‡Q|

Avgviv wek¦vm Kwi MÖvn‡Ki mš‘wó AR©b Ges Zv eRvq ivLvi RbÄvgv‡ì eëmvwqK Kvh©µg Dbœq‡bi avivevwnKZv eRvq ivLv Ges bZzb Jla D™¢veb I evRviRvZ Kivi †Kvb weKí †bB|

Avgiv Jl‡ai cwimxgv e„w×‡Z m‡ev©Ëg cÖ‡Póv Pvwj‡q hvw”Q| Gi cwi‡cÖw¶‡Z 2015-16 A_© eQ‡i Proliv Power GesSalpac bvgK `yBwU Jla evRv‡i G‡bwQ hv Avgv‡ì Ab¨vb¨Jl‡ai gZ MÖvn‡Ki mš‘wó AR©‡b mdj n‡e e‡j Avgiv Avkvev`x|

cÖwZ eQi Avcbv‡ì †Kv¤úvbx Av‡qi GKwU D‡j-L‡hvM¨ Ask RvZxq †KvlvMv‡i cÖ`vb K‡i Avm‡Q| Av‡jvP¨ A_©eQi Iwiqb BbwdDkb wjwg‡UW f¨vU, U¨v·, BZ¨vw` ïé eve` 158.93 wgwjqb UvKv RvZxq †KvlvMv‡i Rgv w`‡q‡Q hv bxU weµ‡qi21.77%|

Avgvi wcÖq †kqvi‡nvìvie„›`, Avwg Avcbv‡ì Avk¦vm w`w”Q †h,Avgviv h_vmg‡q mKj ai‡bi AvBb-Kvbyb, wb‡`©wkKv †g‡b Pjvi e¨vcv‡i e×cwiKi| evsjv‡`k wmwKDwiwUR GÛ G·‡PÄ Kwgkb KZ…©K mKj ZvwjKvf~³ †Kv¤úvbxi Rb¨ RvixK…Z K‡cv©‡iUMf‡b©Ý MvBWjvBb Gi bxwZgvjvI Avgiv h_v‡hvM¨fv‡e cvjb K‡i AvmwQ Ges Avcbv‡ì AeMwZi Rb¨ evwl©K cÖwZ‡e`‡b Gi Dci we¯—vwiZ Av‡jvPbv Kiv n‡q‡Q|

Avw_©K Kvh©µg cwiPvjbvi cvkvcwk Avgiv wewfbœ mvgvwRK Ges `vZe¨ Kvh©µ‡gi mv‡_ mwµqfv‡e RwoZ| DbœZ †`k Movi j‡¶¨ wewfbœ iKg wk¶vg~jK Ges mgvRKj¨vbg~jK Kg©KvÛcwiPvjbv K‡i AvmwQ| mg‡qi cwiµgvq Avgv‡ì G ai‡bimgvR‡mevg~jK D‡`¨v‡Mi mv‡_ Avgv‡ì m¤ú„³Zv AviI evov‡bvi cÖ‡Póv Pvwj‡q hve| Avcbviv AviI †R‡b Lywk n‡eb †h,Avgiv cwi‡ekevÜe cÖhyw³ eënvi K‡i Avgv‡ì eëmvcwiPvjbv K‡i AvmwQ Ges mg‡qvc‡hvMx wewfbœ †KŠkj Aej¤^bK‡i _vwK|

Avgiv abëv` Ávcb KiwQ Iwiqb BbwdDk‡bi mKj Kgx©e„‡›ìcÖwZ hv‡ì AvKzô cwikª‡gi Kvi‡YB Avcbv‡ì †Kv¤úvbx eZ©gvbAe¯’v‡b Avm‡Z †c‡i‡Q| GKB m‡½ Avgv‡ì mKj MÖvnK,e¨vsK, Avw_©K cÖwZôvb, mieivnKvix, miKvix wefvM mgyn I wbqš¿bKvix ms¯’v mn Avgv‡ì Kg©Kv‡Êi mv‡_ cÖZ¨¶ Ges c‡iv¶fv‡e m¤ú„³ mKj‡K Avš—wiK abëv` Ges K…ZÁZvRvbvw”Q|

¯^v/-

†gvnv !` Ievq`yj Kwig†Pqvig¨vb

Iwiqb BbwdDkb cwiev‡ii m !vwbZ †kqvi‡nvìvie„›`,


Started export to Somalia from November 2016

Product registrationcompleted inEgypt and Myanmar

Product Registrationunder process in

Cambodia, Sri Lanka, Nepal,

Yemen and Azerbaijan

Introduction of monthlyview exchange meetingwith employees to

make employer-employee

relationship stronger

BDT 1.40 per share dividendProposed by the Board of Directors

KEY FACTS


Revenue increased by 10.15%2014-15: BDT 662,837,116

EPS increased by 277.7%2014-15: BDT 1.39

Gross Profit increased by 10.45%2014-15: BDT 261,150,887

NAV/share increased by 40.93%2014-15: BDT 9.21

Operating Profit increased by 14.15%2014-15: BDT 85,195,312

Net Profit (AT) increased by 278.69%2014-15: BDT 28,251,578

NOCF/share increased by 50.91%2014-15: BDT 3.41

HIGHLIGHTS OF OUR PERFORMANCE


FINANCIAL PERFORMANCE 5 years at a glance

OPERATIONAL RESULT

Net Revenue

Gross Profit

Operating Profit

Net Operating Profit

Net Profit after Tax

FINANCIAL POSITION

Shareholders' equity

Total Assets

Total Current Assets

Total Current Liabilities

FINANCIAL RATIOS

Current Ratio (times)

Debt Equity Ratio (times)

Return on Equity (%)

Return on Total Assets (%)

Inventory Turnover (times)

Price Earning Ratio -DSE (times)

ORDINARY SHARES INFORMATION

Number of Shares Outstanding

Dividend (Cash) (%)

Net Asset Value per Share (BDT)

Net Operating Cash flow per Share (BDT)

Earnings per Share (BDT)

Number of Shareholders

OTHER DATA

Number of Employees

2015-16

730,127

288,453

97,248

124,461

106,985

264,189

707,587

324,360

433,569

0.75

1.68

40.50

15.12

6.16

13.73

20,359,760

14.00

12.98

5.15

5.25

5,032

794

2014-15

662,837

261,151

85,195

35,830

28,252

187,465

719,196

259,002

484,599

0.53

2.84

15.07

3.93

4.74

32.37

20,359,760

13.00

9.21

3.41

1.39

5,261

811

2013-14

656,925

251,077

71,139

93,214

74,104

165,997

716,660

289,700

517,386

0.56

3.32

44.64

10.34

4.34

12.25

20,359,760

15.00

8.15

3.49

3.64

5,488

761

2012-13

611,774

232,690

61,103

37,963

25,936

142,538

703,674

288,645

327,596

0.88

3.94

18.20

7.12

3.93

33.39

20,359,760

12.00

7.00

2.53

1.27

5,581

808

2011-12

601,416

226,101

63,520

36,057

24,271

122,109

620,049

233,653

244,766

0.95

4.08

19.88

8.50

3.06

35.63

20,359,760

16.00

6.00

3.78

1.19

5,429

861

BDT in Thousand


601,

416

22

6,1

01

63

,52

0

24,2

71

611,

77

4

23

2,6

90

61,1

03

25,9

36

656,

925

251,

077

71

,13

9

74,1

04

662,

837

26

1,1

51

85,1

95

28,2

52

730,

12

7

28

8,4

53

97,2

48

106,

98

5

-

100,000

200,000

300,000

400,000

500,000

600,000

700,000

800,000

Sales Revenue Gross Profit Operating Profit Net Profit After Tax

Operating Result (In thousand) 2011-12 2012-13 2013-14 2014-15 2015-16

122,

109

244,

76

6

620,

04

9

23

3,6

53

142,

538

327,

59

6

703,

67

4

288,

645

16

5,9

97

517,

386

716,

66

0

289,

700

187,

465

48

4,5

99

719,

196

259,

002

264,

18

9 43

3,5

69

707,

587

32

4,3

60

-

100,000

200,000

300,000

400,000

500,000

600,000

700,000

800,000

Shareholders' Equity Current Liabilities Total Assets Current Assets

Financial Position (In thousand) 2011-12 2012-13 2013-14 2014-15 2015-16

6.00

3.78

1.19 1.60

7.00

2.531.27 1.20

8.15

3.49 3.64

1.50

9.21

3.41

1.39 1.30

12.98

5.15 5.25

1.40

0.00

2.00

4.00

6.00

8.00

10.00

12.00

14.00

NAV/Share NOCF/Share EPS Cash Dividend/Share

Ordinary Share Information 2011-12 2012-13 2013-14 2014-15 2015-16

GRAPHICAL VIEW of selected growth indicators


The 32nd Annual General Meeting (AGM) for the financial year 2014-15 was held at Officers Club, 26 Baily

Road, Ramna, Dhaka on December 15, 2015. Mr. Mohammad Obaidul Karim, Honorable Chairman of the

Company, presided over the meeting and warmly welcomed all the shareholders for attending the AGM. In

this meeting, shareholders were informed about the performance and future prospect of the Company. The

shareholders also expressed their views and gave valuable suggestions in the meeting.

The Honorable Chairman appreciated the shareholders for their active participations, constructive

suggestions and valuable advices.

The Board members, CFO and

Company Secretary at the 32nd AGM

A shareholder expressing his view at

the 32nd AGM

The Chairman giving his speech at

the 32nd AGM

Shareholders at the 32nd AGM

32nd ANNUAL GENERAL MEETING




Our Business & S trategy


Formation of the Company Commencement

of Production

Introduction of Dextropac, Dextrosal

Introduction of Salpac, Dianak, Dextrosal-mini, Dextrosal-baby, NidazyIV, Dextropac-10, Hartman

Name Changed to Orion Infusion Limited Conversion to

Public Limited Company

Listing in DSE

Introduction of Maprocin IV

Introduction of Dextrosal-ISO

Introduction of Ortac IV, Fructose-10

Introduction of Dextropac-25, Manisol

Listing in CSE

Introduction of Dextropac Dextrosal

Name Changed to Orion Inf i Li it d Conversion to

Listing in DSE Introduction of Listing in CSE

1983 1992

1992

1993

1994 1994

1994

1995 2001

2003

2004

1996

CORPORATE CHRONOLOGY


Introduction of Proliv

Introduction of Orlev IV

Introduction of Proliv-Plus, Plasmasol

Recommencement of trading in main market of DSE

Introduction of Salpac 100 ml

Introduction of Proliv Power, Salpac

Introduction of Maprocin-DS IV

Introduction of Dextrolac, Electrodex-10, Proliv 100 ml

Share trading transferred to OTC market

Dematerialization of physical share certificate

Introduction of Intralipid 10% 500 ml

Introduction of Introduction of Dextrolac,

Dematerializationof physical share Introduction of

2005

2006

2007

2008

2009

20092011

2011

2012

2015

2016


Our Vision

To be regarded as a world-class

pharmaceutical company in the field of

generic finished products.

Our Mission

To improve people's health and achieve

stakeholders' satisfaction by manufacturing

and marketing pharmaceutical finished

products.

Our Values

Quality in everything we do

Live up to our commitment

Transparent and fair in all our dealings

Take initiative to exceed standards

Trust and respect for each other

Work as a team

Share social responsibility

To sustain a significant sales growth

above industry average

To develop employees' skills through

continuous training and development

programs

To be established as one of the most

preferred pharmaceuticals companies in

Bangladesh to work for

To upgrade manufacturing facilities

continuously in order to cope with

changes in the business environment

To assure quality products from our

manufacturing facility through cGMP

To focus on total customer satisfaction

Our Goals

VISION, MISSION, GOALS & VALUES


Ch

ief

Fin

anci

alO

ffic

er

Fin

ance

&A

cco

un

ts

Tax

& V

at

Info

rmat

ion

T

ech

no

log

y (

IT)

Mar

ket

ing

Inte

rnal

Au

dit

Sal

es &

Dis

trib

uti

on

Plan

ning

Pro

cure

men

t&

Inve

ntor

y Co

ntro

l (PP

IC)

Pro

cure

men

t &

Co

mm

erci

al

Pro

du

ctio

n

Qu

alit

y C

on

tro

l

Fac

tory

Ad

min

& S

tore

Civ

il

Ele

ctri

cal

&M

ech

anic

al

HR

Ad

min

Hea

d o

fM

ark

etin

gH

ead

of

Su

pp

ly C

hai

nH

ead

of

Pla

nt

Hea

d o

fE

ng

inee

rin

gH

ead

of

HR

Hea

d o

f A

dm

in

Man

agin

g D

irec

tor

& C

EO

Bo

ard

of

Dir

ecto

r

Ch

airm

an

Sh

areh

old

ers

Au

dit

Com

mit

tee

Co

mp

any

Sec

reta

ry

Co

mp

any

Aff

airs

OR

GA

NO

GR

AM

rd Annual Report - Orion Infusion Ltd · 5 Strategic Business Units WHO ... of the Annual Report together with the Audited Financial Statements including Statement of Financial ...

Documents